Hepatic kinome atlas: An in‐depth identification of kinase pathways in liver fibrosis of humans and rodents
Hepatology2022Vol. 76(5), pp. 1376–1388
Citations Over TimeTop 10% of 2022 papers
Justin F. Creeden, Zachary A. Kipp, Mei Xu, Robert M Flight, Hunter Moseley, Genesee J. Martinez, Wang‐Hsin Lee, Khaled Alganem, Ali Sajid Imami, Megan R. McMullen, Sanjoy Roychowdhury, Atta Nawabi, Jennifer Hipp, Samir Softic, Steven A. Weinman, Robert E. McCullumsmith, Laura E. Nagy, Terry D. Hinds
Abstract
Our findings establish a comprehensive kinase atlas for liver fibrosis, which identifies analogous signaling events conserved among humans and rodents.
Related Papers
- → Rigidification Dramatically Improves Inhibitor Selectivity for RAF Kinases(2019)21 cited
- → PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor(2020)18 cited
- → Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationships(2020)7 cited
- → Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases(2022)3 cited
- SHEDding light on the role of Pragmin pseudo-kinases in cancer.(2019)